PRTN3 and rheumatoid arthritis: We also expressed 16 GT mAbs from the non-RA/PD patient (GT06; frozen biopsy) after preselecting clones with a high level of SHM (>15) and/or N-glycosylation sites [i.e. previously described ACPA characteristics (30, 31, 33)].